SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001517126-14-000205
Filing Date
2014-07-10
Accepted
2014-07-10 17:02:42
Documents
2
Period of Report
2013-06-27
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A form8ka.htm 8-K/A 33122
2 filename2.htm CORRESP 10074
  Complete submission text file 0001517126-14-000205.txt   44940
Mailing Address 12655 N. CENTRAL EXPRESSWAY SUITE 1000 DALLAS TX 75243
Business Address 12655 N. CENTRAL EXPRESSWAY SUITE 1000 DALLAS TX 75243 972-386-7350
Endocan Corporation. (Filer) CIK: 0000054424 (see all company filings)

IRS No.: 900156146 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 002-41703 | Film No.: 14970138
SIC: 4813 Telephone Communications (No Radiotelephone)